Biotech · Private company · Cambridge, MA, US
Kytopen Corp
Track this companyFree. Adds Kytopen Corp to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Non-Activated Natural Killer Cell Engineering For Enhanced Cytotoxic PotentialFiscal year 2025 · $1MNIH RePORTER 5R44AI157181-03 · fetched Nov 12, 2026
- Non-Activated Natural Killer Cell Engineering For Enhanced Cytotoxic PotentialFiscal year 2024 · $581.6KNIH RePORTER 4R44AI157181-02 · fetched Nov 12, 2026